VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 36 filers reported holding VINCERX PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,083,555 | -22.3% | 2,062,926 | -0.0% | 0.00% | -100.0% |
| Q2 2023 | $2,681,835 | +24.9% | 2,062,950 | -0.1% | 0.00% | – |
| Q1 2023 | $2,147,488 | +1.5% | 2,064,892 | -0.5% | 0.00% | – |
| Q4 2022 | $2,115,756 | +11035.6% | 2,074,271 | +14828.2% | 0.00% | – |
| Q3 2022 | $19,000 | -60.4% | 13,895 | -61.5% | 0.00% | – |
| Q2 2022 | $48,000 | -59.7% | 36,126 | +21.3% | 0.00% | – |
| Q1 2022 | $119,000 | – | 29,792 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAGE RHINO CAPITAL LLC | 1,618,199 | $6,473,000 | 1.96% |
| Affinity Asset Advisors, LLC | 1,374,098 | $5,496,000 | 0.88% |
| TANG CAPITAL MANAGEMENT LLC | 1,030,634 | $4,123,000 | 0.82% |
| SPHERA FUNDS MANAGEMENT LTD. | 720,161 | $2,881,000 | 0.41% |
| Rubric Capital Management LP | 2,107,000 | $8,428,000 | 0.30% |
| Long Focus Capital Management, LLC | 430,200 | $1,721,000 | 0.22% |
| SABBY MANAGEMENT, LLC | 327,236 | $1,309,000 | 0.20% |
| Clearline Capital LP | 412,657 | $1,651,000 | 0.19% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 385,000 | $1,540,000 | 0.16% |
| Sio Capital Management, LLC | 102,049 | $408,000 | 0.14% |